Peer review reports
From: Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells
Original Submission | ||
---|---|---|
25 Sep 2019 | Submitted | Original manuscript |
23 Oct 2019 | Reviewed | Reviewer Report - Karim Hosni |
15 Nov 2019 | Reviewed | Reviewer Report - Serawit Deyno |
10 Dec 2019 | Author responded | Author comments - Mitsuki Tabata |
25 Dec 2019 | Reviewed | Reviewer Report - Serawit Deyno |
13 Jan 2020 | Reviewed | Reviewer Report - Karim Hosni |
31 Jan 2020 | Author responded | Author comments - Mitsuki Tabata |
Resubmission - Version 2 | ||
10 Dec 2019 | Submitted | Manuscript version 2 |
21 Feb 2020 | Author responded | Author comments - Mitsuki Tabata |
Resubmission - Version 3 | ||
21 Feb 2020 | Submitted | Manuscript version 3 |
29 Feb 2020 | Author responded | Author comments - Mitsuki Tabata |
Resubmission - Version 4 | ||
29 Feb 2020 | Submitted | Manuscript version 4 |
Publishing | ||
4 Mar 2020 | Editorially accepted | |
14 Mar 2020 | Article published | 10.1186/s12906-020-2879-8 |